Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001178913-09-001151
Filing Date
2009-05-14
Accepted
2009-05-14 16:03:49
Documents
1
Group Members
AVRAHAM LIVNATCLAL BIOTECHNOLOGY INDUSTRIES LTD.IDB DEVELOPMENT CORPORATION LTD.IDB HOLDING CORPORATION LTD.NOCHI DANKNERRUTH MANORSHELLY BERGMAN

Document Format Files

Seq Description Document Type Size
1 zk96774.htm SC 13D/A 67350
  Complete submission text file 0001178913-09-001151.txt   69746
Mailing Address 3 AZRIELI CENTER, TRIANGLE TOWER 45TH FLOOR TEL AVIV L3 67023
Business Address 3 AZRIELI CENTER, TRIANGLE TOWER 45TH FLOOR TEL AVIV L3 67023 97236075794
CLAL INDUSTRIES & INVESTMENTS LTD (Filed by) CIK: 0001051856 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: SC 13D/A

Mailing Address 72 PINCHAS ROSEN ST TEL AVIV L3 69512
Business Address 72 PINCHAS ROSEN ST TEL AVIV L3 69512 011-972-3-765-8585
COMPUGEN LTD (Subject) CIK: 0001119774 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-60609 | Film No.: 09826678
SIC: 2836 Biological Products, (No Diagnostic Substances)